ANIP - ANI Pharmaceuticals: Significantly Undervalued
Ignorance is relatively easy to overcome; stupidity is much harder."? Marty Rubin
Today, we take a look at a stock that has fallen on some hard times as it jettisoned its long-term CEO and faced other short-term challenges. However, with management changes and other potential catalysts on the horizon, the shares do look oversold. The stock does seem to be trying to form a bottom at current trading levels as well. A 'deep dive' on this concern is provided in the paragraphs below.
Company Overview
ANI Pharmaceuticals, Inc. (ANIP) is a Baudette,